Citron Research out with its latest report, this time on USANA Health Sciences, Inc. (NYSE:USNA)
This week multiple media outlets in China have exposed the MLM schemes operated by USANA Health Sciences, Inc. (NYSE:USNA) in China — a must read for all investors.
USANA Health Sciences, Inc. (NYSE:USANA)’s revenue growth are dependent on widespread illegal MLM operations in China
It is Citron’s belief that as much as 1/3rd of USANA Health Sciences, Inc. (NYSE:USNA)’s revenue and half its revenue growth are dependent on widespread illegal MLM operations in China. Last year, we documented voluminous examples of dozens of duplicate addresses in USNA’s distributor database purportedly residing in empty apartment blocks in Hong Kong, and Hong Kong labeled product being offered for sale in mainland China.
This Tiger Cub Giant Is Betting On Banks And Tech Stocks In The Recovery
The first two months of the third quarter were the best months for D1 Capital Partners' public portfolio since inception, that's according to a copy of the firm's August update, which ValueWalk has been able to review. Q2 2020 hedge fund letters, conferences and more According to the update, D1's public portfolio returned 20.1% gross Read More
Over the course of the last eighteen months, Citron has covered the problems of Utah-based MLM’s who have been posting outsized revenue and revenue growth from China. In January 2014, the People’s Daily, long regarded as the “house organ” of the Chinese government, reported on a government investigation of Nu Skin Enterprises, Inc. (NYSE:NUS), causing a 50% cliff-dive in the stock which has never recovered.
Citron points out the risk that history is about to repeat itself, this time for USANA Health Sciences, Inc. (NYSE:USNA).
It is Citron’s belief that USANA is one of the most egregious violators of China’s “anti-pyramid scheme laws” which effectively prohibit MLM’s primary business model – multi-level compensation schemes for recruiting and enrolling new sales agents. The main reason, as documented extensively in our 2013 piece here, was that USNA doesn’t even own a retail license in China for neutraceutical product; its entire mainland operation for distributing them requires the charade of Hong-Kong sales associates who actually live and operate in mainland China.
So now, in the same pattern we saw with Nu Skin, the news is heating up for USANA Health Sciences, Inc. (NYSE:USNA).
We now wait for the next shoe to drop.
Cautious Investing To All.
USANA’s MLM Scheme in China is now National News via Citron Research